Zurcher Kantonalbank (Zurich Cantonalbank) Vertex Pharmaceuticals Inc Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 320,144 shares of VRTX stock, worth $150 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

320,144

Previous 320,144 -0.0%

Holding current value

$150 Million

Previous $149 Million -0.0%

% of portfolio

0.45%

Previous 0.45%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$460.0 - $505.78 $31.6 Million - $34.7 Million	-68,702 Reduced 17.67%	320,144 $149 Million
Q2 2024 Jul 29, 2024	SELL	$392.81 - $485.53 $17.9 Million - $22.1 Million	-45,488 Reduced 10.47%	388,846 $182 Million
Q1 2024 Apr 25, 2024	SELL	$407.69 - $446.08 $4.42 Million - $4.84 Million	-10,853 Reduced 2.44%	434,334 $182 Million
Q4 2023 Jan 30, 2024	BUY	$343.0 - $410.68 $6.24 Million - $7.47 Million	18,186 Added 4.26%	445,187 $181 Million
Q3 2023 Oct 25, 2023	BUY	$338.18 - $362.46 $1.86 Million - $2 Million	5,514 Added 1.31%	427,001 $148 Million
Q2 2023 Aug 07, 2023	BUY	$314.42 - $351.91 $8.33 Million - $9.32 Million	26,496 Added 6.71%	421,487 $148 Million
Q1 2023 May 08, 2023	BUY	$283.23 - $323.1 $2.87 Million - $3.27 Million	10,120 Added 2.63%	394,991 $124 Million
Q4 2022 Feb 01, 2023	SELL	$285.76 - $321.48 $2.77 Million - $3.11 Million	-9,688 Reduced 2.46%	384,871 $111 Million
Q3 2022 Nov 09, 2022	BUY	$273.83 - $305.53 $9.16 Million - $10.2 Million	33,449 Added 9.26%	394,559 $114 Million
Q2 2022 Aug 09, 2022	BUY	$234.96 - $292.55 $17.5 Million - $21.8 Million	74,543 Added 26.01%	361,110 $102 Million
Q1 2022 Apr 21, 2022	BUY	$221.42 - $260.97 $35.5 Million - $41.8 Million	160,264 Added 126.89%	286,567 $74.8 Million
Q4 2021 Feb 01, 2022	SELL	$177.01 - $223.45 $3.42 Million - $4.31 Million	-19,306 Reduced 13.26%	126,303 $27.7 Million
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $716,671 - $802,013	-3,951 Reduced 2.64%	145,609 $26.4 Million
Q2 2021 Jul 30, 2021	BUY	$187.49 - $221.1 $10.2 Million - $12 Million	54,229 Added 56.88%	149,560 $30.2 Million
Q1 2021 May 03, 2021	BUY	$207.02 - $241.31 $2.98 Million - $3.47 Million	14,395 Added 17.79%	95,331 $20.5 Million
Q4 2020 Jan 28, 2021	BUY	$207.01 - $276.09 $1.85 Million - $2.47 Million	8,950 Added 12.43%	80,936 $19.1 Million
Q3 2020 Nov 06, 2020	BUY	$255.65 - $303.1 $2.66 Million - $3.16 Million	10,418 Added 16.92%	71,986 $19.6 Million
Q2 2020 Jul 28, 2020	SELL	$225.48 - $295.8 $4.33 Million - $5.68 Million	-19,210 Reduced 23.78%	61,568 $17.9 Million
Q1 2020 May 06, 2020	BUY	$199.77 - $247.81 $4.04 Million - $5.01 Million	20,199 Added 33.34%	80,778 $19.2 Million
Q4 2019 Jan 21, 2020	BUY	$166.71 - $223.91 $1.27 Million - $1.7 Million	7,604 Added 14.35%	60,579 $13.3 Million
Q3 2019 Oct 18, 2019	BUY	$166.23 - $187.09 $215,434 - $242,468	1,296 Added 2.51%	52,975 $8.98 Million
Q2 2019 Jul 30, 2019	SELL	$164.61 - $190.37 $1.12 Million - $1.29 Million	-6,800 Reduced 11.63%	51,679 $9.48 Million
Q1 2019 Apr 29, 2019	BUY	$163.73 - $194.7 $1.56 Million - $1.86 Million	9,551 Added 19.52%	58,479 $10.8 Million
Q4 2018 Jan 25, 2019	SELL	$151.91 - $192.21 $11.3 Million - $14.4 Million	-74,701 Reduced 60.42%	48,928 $8.11 Million
Q3 2018 Nov 09, 2018	SELL	$167.73 - $192.74 $749,753 - $861,547	-4,470 Reduced 3.49%	123,629 $23.8 Million
Q2 2018 Aug 06, 2018	SELL	$145.72 - $169.96 $555,338 - $647,717	-3,811 Reduced 2.89%	128,099 $21.8 Million
Q1 2018 May 03, 2018	BUY	$151.6 - $177.13 $1.5 Million - $1.75 Million	9,887 Added 8.1%	131,910 $21.5 Million
Q4 2017 Jan 31, 2018	BUY	$137.28 - $155.55 $3.91 Million - $4.43 Million	28,496 Added 30.47%	122,023 $18.3 Million
Q3 2017 Nov 08, 2017	BUY	$148.13 - $162.24 $13.9 Million - $15.2 Million	93,527	93,527 $14.2 Million

Others Institutions Holding VRTX

# of Institutions

1,725

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Vertex Pharmaceuticals Inc Transaction History